感染症グループ業績
業績
2024年
Original Article
-
The Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission.
Cureus 16(5): e61470, 2024Pubmed
The Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission.
Cureus 16(5): e61470, 2024Pubmed